Fifth Third Bancorp
COLL icon

Fifth Third Bancorp’s Collegium Pharmaceutical COLL Stock Holding History

Fifth Third Bancorp’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$962K Buy
29,092
+28,913
+16,153% +$1.22M ﹤0.01% 1664
2025
Q4 		$8.29K Buy
179
+11
+7% +$460 ﹤0.01% 2186
2025
Q3 		$5.88K Buy
168
+57
+51% +$1.98K ﹤0.01% 2290
2025
Q2 		$3.28K Buy
111
+6
+6% +$171 ﹤0.01% 2284
2025
Q1 		$3.13K Buy
105
+32
+44% +$978 ﹤0.01% 2283
2024
Q4 		$2.09K Sell
73
-1
-1% -$33 ﹤0.01% 2313
2024
Q3 		$2.86K Buy
74
+4
+6% +$143 ﹤0.01% 2300
2024
Q2 		$2.25K Buy
70
+17
+32% +$589 ﹤0.01% 2252
2024
Q1 		$2.06K Buy
53
+5
+10% +$175 ﹤0.01% 2213
2023
Q4 		$1.48K Hold
48
– – ﹤0.01% 2375
2023
Q3 		$1.07K Hold
48
– – ﹤0.01% 2454
2023
Q2 		$1.03K Sell
48
-602
-93% -$13.7K ﹤0.01% 2507
2023
Q1 		$15.6K Buy
650
+602
+1,254% +$16K ﹤0.01% 1917
2022
Q4 		$1.11K Hold
48
– – ﹤0.01% 2520
2022
Q3 		$1K Hold
48
– – ﹤0.01% 2526
2022
Q2 		$1K Buy
+48
New +$807 ﹤0.01% 2509

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Fifth Third Bancorp's COLL Position: Q1 2026 in Review

Fifth Third Bancorp increased its Collegium Pharmaceutical (COLL) stake by 16,153% in Q1 2026, buying an estimated $1.22M and bringing the position to 29,092 shares worth $962K. The position accounts for ﹤0.01% of the portfolio, ranked #1664.

Fifth Third Bancorp first reported a position in COLL in Q2 2022 and has held it in 16 quarters since. 266 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

  • Fifth Third Bancorp held 29,092 shares of Collegium Pharmaceutical worth $962K as of Q1 2026.
  • Fifth Third Bancorp bought 28,913 Collegium Pharmaceutical shares in Q1 2026, an estimated $1.22M.
  • Collegium Pharmaceutical made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q1 2026, its #1664 holding.
  • Fifth Third Bancorp first reported a position in Collegium Pharmaceutical in Q2 2022 and has held it in 16 quarters since.
  • 266 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on Fifth Third Bancorp's 13F filing for Q1 2026, filed 1 May 2026.